Beranda › Kanker (semua jenis) › Texas › Irving
Uji klinis Kanker (semua jenis) di Irving, TX
15 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Irving (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
REC-7735 in Participants With Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology - Dallas, Irving
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Menerima pesertaFase 1
- NEXT Dallas, Irving
Registry Study for Radiation Therapy Outcomes
Menerima pesertaStudi observasional
- Texas Center for Proton Therapy, Irving
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Menerima pesertaFase 3
- US Oncology Research Investigational Products Center, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- NEXT Dallas, Irving
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Menerima pesertaFase 1
- NEXT Oncology ( Site 0051), Irving
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Menerima pesertaFase 1/2
- NEXT Oncology ( Site 1012), Irving
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Menerima pesertaFase 1/2
- NEXT Oncology Dallas, Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology Dallas, Irving
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Dallas, Irving
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Dallas, Irving
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology, Irving
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Menerima pesertaFase 1
- NEXT Oncology, Irving
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Menerima pesertaFase 1/2
- NEXT Dallas, Irving
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
Menerima pesertaStudi observasional
- Texas Center for Proton Therapy, Irving
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Studi lain di Irving
- Kanker Paru Non-Sel Kecil22 studi
- Kanker Kolorektal13 studi
- Kanker Metastatik11 studi
- Kanker Pankreas7 studi
- Kanker Lambung7 studi
- Karsinoma Sel Skuamosa Kepala dan Leher6 studi
- Kanker Payudara6 studi
- Kanker Paru Sel Kecil6 studi
- Kanker Paru6 studi
- Kanker Ovarium5 studi
- Kanker Endometrium4 studi
- Kanker Prostat4 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.